Publications
5674 Results
- Journal / Conference
- San Antonio Breast Cancer Symposium (December 5-9, 2017, San Antonio, TX), poster discussion
- Year
- 2017
- Research Committee(s)
- Breast
Long-term follow-up (FU) of (Alliance) CALGB 40502/NCCTG N063H: A randomized Phase III Trial of Weekly Paclitaxel (P) compared to Weekly Nanoparticle Albumin Bound Nab-Paclitaxel (NP) or Ixabepilone (Ix) +/- Bevacizumab (B) as First-Line Therapy for Locally Recurrent or Metastatic Breast Cancer (MBC)
- Journal / Conference
- San Antonio Breast Cancer Symposium (December 5-9, 2017, San Antonio, TX), poster
- Year
- 2017
- Research Committee(s)
- Breast
- Study Number(s)
- E2197
Independent validation of EarlyR gene signature in E2197: a randomized clinical trial comparing doxorubicin plus docetaxel to doxorubicin plus cyclophosphamide as adjuvant chemotherapy in breast cancer
- Journal / Conference
- International Symposium on Acute Promyelocytic Leukemia (September 24-27, 2017, Rome, Italy), oral presentation
- Year
- 2017
- Research Committee(s)
- Leukemia
- Study Number(s)
- C9710, S0535
Mutations in Acute Promyelocytic Leukemia are Similar at Diagnosis and Relapse and ETV6 may be a Molecular Biomarker of Decreased Disease Free Survival and High Risk Disease Independent of White Blood Count
- Journal / Conference
- Journal of Clinical Oncology Nov 1;35(31):3525-3528; Aug 30 [Epub ahead of print]
- Year
- 2017
- Research Committee(s)
- Genitourinary
- PMID
- PMID28854068
- PMC
- PMC5791831
Practice makes perfect- The rest of the story in testicular cancer as a model curable neoplasm
- Journal / Conference
- San Antonio Breast Cancer Symposium (December 5-9, 2017, San Antonio, TX), poster
- Year
- 2017
- Research Committee(s)
- Prevention, Screening, and and Surveillance
- Study Number(s)
- S0812
Randomized Double-Blind Placebo-Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer (SWOG S0812)
- Journal / Conference
- San Antonio Breast Cancer Symposium (December 5-9, 2017, San Antonio, TX), poster
- Year
- 2017
- Research Committee(s)
- Breast
SWOG S1418/NRG -BR006: A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of MK-3475 as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer with > 1 cm Residual Invasive Cancer or Positive Lymph Nodes (>pN1mic) After Neoadjuvant Chemotherapy
- Journal / Conference
- IASLC World Conference on Lung Cancer (October 15 - 18 2017, Yokohama, Japan), abst. OA 14.07, oral presentation
- Year
- 2017
- Research Committee(s)
- Lung
- Study Number(s)
- S1400, S1400A, S1400B, S1400C, S1400D
Progress in lung squamous cell carcinoma from the Lung-MAP master protocol (S1400) sub-studies S1400A, S1400B, S1400C and S1400D
- Journal / Conference
- IASLC World Conference on Lung Cancer (October 15 - 18 2017, Yokohama, Japan), poster presentation, abst. P3.01-046
- Year
- 2017
- Research Committee(s)
- Lung
- Study Number(s)
- S1403
Longitudinal analysis of plasma ctDNA in EGFR-mutant NSCLC: SWOG S1403 trial of afatinib with or without cetuximab
- Journal / Conference
- IASLC World Conference on Lung Cancer (October 15 - 18 2017, Yokohama, Japan), accepted, oral
- Year
- 2017
- Research Committee(s)
- Lung
- Study Number(s)
- S0339, S0342, SWOG-9308, SWOG-9509, S9806
A Clinical Prognostic Model for Survival of Elderly Patients with Non-Small Cell Lung Cancer
- Journal / Conference
- Breast Cancer Research and Treatment Jul;164(2):371-378
- Year
- 2017
- Research Committee(s)
- Breast
- PMID
- PMID28447237
- PMC
- PMC5798974